- Drug Pipelines
- April 2024
- 220 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Report
- August 2022
- 30 Pages
Global
From €2676EUR$2,750USD£2,292GBP
- Report
- August 2022
- 30 Pages
Global
From €2676EUR$2,750USD£2,292GBP
- Report
- August 2022
- 30 Pages
Global
From €2676EUR$2,750USD£2,292GBP
- Report
- August 2022
- 30 Pages
Global
From €2676EUR$2,750USD£2,292GBP
- Report
- August 2022
- 30 Pages
Global
From €2676EUR$2,750USD£2,292GBP
- Drug Pipelines
- January 2023
- 30 Pages
United States
From €2676EUR$2,750USD£2,292GBP
- Report
- March 2022
- 324 Pages
Global
From €9243EUR$9,500USD£7,918GBP
- Drug Pipelines
- March 2022
- 162 Pages
Global
From €5546EUR$5,700USD£4,751GBP
- Report
- August 2022
Global
From €963EUR$990USD£825GBP
- Drug Pipelines
- July 2020
- 302 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Drug Pipelines
- March 2021
Global
From €2432EUR$2,500USD£2,084GBP
Analgesics are drugs used to relieve pain. The Post Operative Pain Drug market is a subset of the analgesic market, and is focused on drugs used to treat pain after surgery. These drugs are typically administered intravenously or orally, and are designed to reduce the intensity of pain and the amount of time it takes for the patient to recover. Common drugs used in this market include opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and local anesthetics.
The Post Operative Pain Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in this market include Pfizer, Johnson & Johnson, Merck & Co., Novartis, and Sanofi. Show Less Read more
